Selenium Metabolic Status Diagnosis via Protein Electrophoresis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to specifically determine the metabolic state of organic forms of selenium in mammals, which is crucial for assessing nutritional status and preventing diseases like cancer and cardiovascular disease, as they cannot distinguish between organic and inorganic forms of selenium or adequate versus supra-nutritional levels.
Innovation Solution
A protein electrophoretic pattern is used to determine the metabolic state of selenium by analyzing plasma proteins with a basic isoelectric point, identifying and quantifying specific bands such as R-3, R-10, R-11, R-12, R-13, and R-15, and comparing these results to a reference pattern associated with a supranutritional metabolic state.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional analytical methods are used to determine selenium concentration, then total selenium levels can be measured, but the methods cannot distinguish between organic and inorganic forms of selenium or between adequate and supra-nutritional levels
Solution Approach 1:
The patent uses selenoprotein P as an intermediary biomarker that specifically reflects organic selenium metabolism. Instead of directly measuring total selenium (which mixes organic and inorganic forms), the method measures selenoprotein P levels, which are exclusively synthesized from organic selenium. This intermediary approach enables precise differentiation of selenium forms and nutritional status without requiring complex separation and identification procedures.
2Reliability
If supra-nutritional doses of selenium are administered to achieve chemopreventive effects, then cancer prevention and immune response improve, but the risk of selenium toxicity increases
Solution Approach 1:
The patent establishes a feedback mechanism by measuring selenoprotein P levels to monitor organic selenium status in real-time. This allows dynamic adjustment of supplementation doses: when selenoprotein P reaches optimal levels, supplementation is reduced or stopped to prevent toxicity; when levels are insufficient, supplementation is increased to achieve chemopreventive effects. This closed-loop control ensures therapeutic benefits while avoiding harmful toxicity.
3Reliability
If selenium supplementation is provided without monitoring metabolic status, then nutritional deficiency can be prevented, but resources are wasted on unnecessary supplementation and potential toxicity occurs
Solution Approach 1:
The patent implements feedback-based monitoring by measuring selenoprotein P levels to determine actual organic selenium status. This enables targeted supplementation only when needed: individuals with low selenoprotein P receive supplementation, while those with adequate levels do not. This eliminates wasteful universal supplementation and prevents toxicity in already-sufficient individuals, optimizing resource allocation.
Solution Approach 2:
The patent empowers individuals to self-monitor their selenium status through selenoprotein P measurement and make informed decisions about supplementation. By providing accessible diagnostic tools and clear interpretation guidelines, the system enables self-service health management, reducing reliance on expensive medical interventions and allowing individuals to optimize their own nutritional status efficiently.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the accurate assessment of selenium metabolic status, enabling the identification of adequate or deficient intake and reducing the risk of diseases associated with selenium imbalance, thereby guiding dietary supplementation.
Implementation Method 1
a protein electrophoretic pattern is used to determine the metabolic state of selenium by analyzing plasma proteins with a basic isoelectric point
Data Source
AI summary
The disclosure provides methods and kits for diagnosing the nutritional state of selenium, using six proteins as biomarkers for which the expression increases when the metabolic state is supra-nutritional.